A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)

NCT01513291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine
Headache

Interventions

DRUG: MK-6096
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC